Evidence map›Paper›PMID 34650437›Full record

ArticleFrontiers in pharmacology2021

Nox4 Promotes RANKL-Induced Autophagy and Osteoclastogenesis via Activating ROS/PERK/eIF-2α/ATF4 Pathway.

Jing Sun, Wugui Chen, Songtao Li, Sizhen Yang, Ying Zhang, Xu Hu, Hao Qiu, Jigong Wu, Shangcheng Xu, Tongwei Chu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Nutrition research and practice · 2024
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jing SunDepartment of Orthopedics, Xinqiao Hospital of Army Medical University, Chongqing, China.
Wugui ChenDepartment of Orthopedics, Xinqiao Hospital of Army Medical University, Chongqing, China.
Songtao LiDepartment of Orthopedics, Xinqiao Hospital of Army Medical University, Chongqing, China.
Sizhen YangDepartment of Orthopedics, Xinqiao Hospital of Army Medical University, Chongqing, China.
Ying ZhangDepartment of Orthopedics, Xinqiao Hospital of Army Medical University, Chongqing, China.
Xu HuDepartment of Orthopedics, Xinqiao Hospital of Army Medical University, Chongqing, China.
Hao QiuDepartment of Orthopedics, Xinqiao Hospital of Army Medical University, Chongqing, China.
Jigong WuDepartment of Spinal Surgery, 306 Hospital of PLA, Beijing, China.
Shangcheng XuThe Center of Laboratory Medicine, The Sixth People's Hospital of Chongqing, Chongqing, China.
Tongwei ChuDepartment of Orthopedics, Xinqiao Hospital of Army Medical University, Chongqing, China.
Army Medical University · CNXinqiao Hospital · CNPLA 306 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Receptor activator of nuclear factor-κB ligand (RANKL) has been found to induce osteoclastogenesis and bone resorption. However, the underlying molecular mechanisms remain unclear. Via conducting a series of biochemical experiments with

Indexed as

autophagyNOX4osteoclastogenesisPERK/eIF-2α/ATF4 pathwayRANKLROSUPR

Identifiers

PMID34650437
PMCPMC8505706
OpenAlexW3162309912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.